Perrigo (NYSE:PRGO) Updates FY25 Earnings Guidance

Perrigo (NYSE:PRGO) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share guidance of $2.90-3.10 for the period, compared to the consensus earnings per share estimate of $3.01. The company issued revenue guidance of +1-3% yr/yr to $4.42-4.51 billion, compared to the consensus revenue estimate of $4.62 billion. Perrigo also updated its FY 2025 guidance to 2.900-3.100 EPS.

Perrigo Price Performance

Perrigo stock opened at $28.98 on Friday. Perrigo has a 52 week low of $23.14 and a 52 week high of $33.46. The company’s 50 day moving average price is $24.94 and its two-hundred day moving average price is $26.19. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The stock has a market cap of $3.95 billion, a P/E ratio of -24.76 and a beta of 0.54.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. On average, equities analysts predict that Perrigo will post 2.56 earnings per share for the current year.

Perrigo Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th will be issued a dividend of $0.29 per share. This is a boost from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a yield of 4.00%. Perrigo’s payout ratio is presently -92.80%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. StockNews.com cut shares of Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $34.00 to $27.00 in a report on Monday, January 6th. Finally, Argus cut shares of Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $33.00.

Insider Buying and Selling

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the transaction, the director now owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.70% of the stock is owned by insiders.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.